Buscar
Mostrando ítems 21-30 de 176
Microencapsulation of cellular aggregates composed of diferentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
(2020)
Background: In type I diabetes mellitus (T1DM) pancreatic β cells are destroyed. Treatment entails exogenous insulin administration and strict diet control, yet optimal glycemic control is hardly attainable. Islet transplant ...
The Autophagy Protein Pacer Positively Regulates the Therapeutic Potential of Mesenchymal Stem Cells in a Mouse Model of DSS-Induced Colitis
(2022)
Mesenchymal stem cells (MSC) have emerged as a promising tool to treat inflammatory diseases, such as inflammatory bowel disease (IBD), due to their immunoregulatory properties. Frequently, IBD is modeled in mice by using ...
Intranigral Transplantation of Epigenetically Induced BDNF-Secreting Human Mesenchymal Stem Cells: Implications for Cell-Based Therapies in Parkinson’s Disease
(Biology of Blood and Marrow Transplantation Volume 16, Issue 11, November 2010, Pages 1530-1540, 2010)
It is thought that the ability of human mesenchymal stem cells (hMSC) to deliver neurotrophic factors might be potentially useful for the treatment of neurodegenerative disorders. The aim of the present study was to ...
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?
(Frontiers Research Foundation, 2021)
Clinical neurofunctional rehabilitation of a cat with spinal cord injury after hemilaminectomy and autologous stem cell transplantation
(Korean Society for Stem Cell Research, 2014)
The amniotic fluid as a source of mesenchymal stem cells with lung‐specific characteristics
(2017)
The amniotic fluid is a clinically accessible source of mesenchymal stem cells (AF‐MSC) during gestation, which enables autologous cellular therapy for perinatal disorders. The origin of AF‐MSC remains elusive: renal and ...